SEC charges GSK unit with fraud - SEC charges GSK unit with fraud The agency alleges Stiefel Laboratories and its former chief executive bought back shares from employees and shareholders at undervalued prices Source: Pharmaceuticals companies news from the Financial Times Psychology, Special Needs & Health.